Tyra Biosciences, Inc. (TYRA) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$132.76M | -27.4% |
| 2024 | -$104.18M | -30.3% |
| 2023 | -$79.94M | -35.7% |
| 2022 | -$58.93M | -124.2% |
| 2021 | -$26.29M | -182.8% |
| 2020 | -$9.30M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$132.76M | -27.4% |
| 2024 | -$104.18M | -30.3% |
| 2023 | -$79.94M | -35.7% |
| 2022 | -$58.93M | -124.2% |
| 2021 | -$26.29M | -182.8% |
| 2020 | -$9.30M | — |